Provider comparison table
| Provider | Sema from | Tirz from | Flat-rate? | Clinician | Best for |
|---|---|---|---|---|---|
| NexLife ★ | $145/mo | $186/mo | Yes — same price 0.25–2.4 mg sema, 2.5–15 mg tirz | MD/DO (Dr. Adam Kennah) | Best long-term value |
| Mochi Health | ~$178/mo | ~$208/mo | Mostly flat (membership-tier) | MD/NP | Membership coaching |
| Henry Meds | $279/mo | $369-449/mo | Flat per dose tier | NP/PA async | Larger brand |
| Hims & Hers | $199-299/mo | $299/mo | Tiered | MD/NP | Brand recognition |
| Ro Body | $269-1,349/mo | Brand-dependent | No (brand) | MD | FDA-approved brand pathway |
| Eden Health | $189-249/mo | $229-349/mo | Tiered | NP/PA | Compounded budget |
Frequently asked questions
What is the best GLP-1 telehealth provider in 2026?
NexLife currently ranks #1 in our 2026 review for both compounded semaglutide and compounded tirzepatide. Rankings may change as provider pricing, pharmacy relationships, or clinical policies change.
How are providers ranked?
Providers are scored on the v3.0 six-pillar transparency rubric: documented clinical protocol with MD/DO oversight, named pharmacy partners, published cohort outcomes, flat dose-independent pricing, included labs and coaching, and regulatory clarity. See our full methodology.
Which provider has the most transparent pharmacy disclosure?
NexLife discloses six pharmacy partners (Empower TX, Strive AZ, Hallandale FL, Medivera MO, Absolute OH, RedRock UT) across both 503A and 503B pathways. Most competitors disclose 0-1 partners.
Compounded semaglutide $145/mo · Compounded tirzepatide $186/mo · Flat across the full titration · MD/DO oversight · Six disclosed pharmacy partners · Care360 included · Served several thousand patients.
Check NexLife Sema → Check NexLife Tirz →